Location: Home
  • search
  • go
  • Relate News
  • 12/10/2024NHSA and NHC Jointly Issue New Policy Document on Centralized Drug Pro...
  • 12/10/2024Abbisko Reports Promising Preliminary Phase 2 Data for Pimicotinib in ...
  • 12/10/2024Loncastuximab Tesirine Gains Approval in China for 3L r/r DLBCL Treatm...
  • 12/10/2024Merck's Keytruda Gains First Approval in China for Cervical Cancer Tre...
  • 12/10/2024Sperogenix's Vamorolone Approved in China for DMD
  • 12/10/2024China Biopharma CDMOs Win Reprieve as Biosecure Act Omitted from US De...
  • 12/10/2024Beijing Hanmi Launches $98.65M Expansion Project Near Capital Airport
  • 12/10/2024China Biopharma Tracker – November 2024 (PharmaDJ)
  • 12/10/2024How Wholly Foreign-Owned Hospitals Can Help China's Health Care Sector...
  • 12/10/2024The New Draft Administrative Measures For Management Of Medical Repres...
  • 12/9/2024Belief Biomed Unveils Promising Gene Therapy Data at ASH 2024
  • 12/6/2024Medical Costs in Mainland China and Hong Kong to Grow More Slowly Than...
  • 12/6/2024CDE Seeks Comments on Draft ICH Guidelines M15
  • 12/6/2024Recent Executive Moves
  • 12/5/2024SK Biopharm Advances Epilepsy Treatment in China with NDA Submission ...
  • 12/5/20242025 Trends Buoying Boom Phase in APAC (Biospectrum)
  • 12/5/2024Big Pharma Doubles Down on China (The Wire China)
  • 12/3/2024Big Pharma's Bet on China Biotech Is a Rare Trade Bright Spot (Bloomb...
  • 12/3/2024CMS Gains Licenses Class 1 New Drug Targeting Gout and Hyperuricemia f...
  • 12/3/2024Sanofi Allocates €1 Billion for New Insulin Manufacturing Facility in...
  • 12/3/2024NHC Minister Meets with Sanofi and BioMérieux Bosses to Strengthen Si...
  • 12/3/2024PharmaMar/Luye's Lurbinectedin Gains Approval in China for Treating Me...
  • 12/3/2024NH DB6: Global and Chinese Consumer Healthcare Market: MAT Q2/2024 Tr...
  • 12/3/2024HUTCHMED and Innovent's ELUNATE and TYVYT Combo Win Chinese Condi...
  • 12/2/2024Everest Medicines Announces Acceptance of VELSIPITY NDA in Hong Kong
  • 12/2/2024Hua Medicine Announces Successful H.K. SENSITIZE Study Results at the ...
  • 12/2/2024Miracogen to Present Phase II Data on MRG003 at ESMO Asia 2024  
  • 12/2/2024Zambon's Xadago (Safinamide) Gains Chinese Approval for Parkinson's Di...
  • 12/2/2024Minghui Pharma Reports Positive Phase III Results for MH004 in Atopic ...
  • 12/2/2024Merck's Recarbrio Approved in China for Severe Bacterial Pneumonia
  • Page:12/354 Total number of articles:10618: [First][<<] [10] [11] [12] [13] [14] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group